SCLXW Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (28 jun 2024 @ 22:00):
Our systems believe the stock currently is overvalued by -0.25% compare to its pairs and should correct downwards.

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain...

Stats
Dagens volum	93 590
Gjennomsnittsvolum	0
Markedsverdi	320.69M
EPS	$-0.240 ( Q1 \| 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0 (Sector) 42.63 (Industry) 61.14
ATR14	$0.0210 (4.67%)

CRXT -31.16%

MIRA -2.00%

SCLX 7.82%

SCLXW 5.24%

Insider Trading

Date	Person	Action	Amount	type
2023-10-04	Ji Henry	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Shah Jaisim	Buy	200 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Wu Yue Alexander	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Chun Jay	Buy	250 000	Nonstatutory Stock Option (right to buy)
2023-10-04	Ma Stephen Hoi	Buy	150 000	Nonstatutory Stock Option (right to buy)

INSIDER POWER
-88.45
Last 30 transactions
Buy: 13 352 730 \| Sell: 150 694 281

Korrelasjon (AI algo v.1.1b): Overvalued: -0.25% $0.451 paired level. (Algoen sporer endringene til de mest korrelerte aksjene i sanntid og gir umiddelbar oppdatering)

Volum Korrelasjon

Lang: -0.19 (neutral)

Kort: -0.55 (weak negative)

Signal:(52.69) Neutral

Scilex Holding Company Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Scilex Holding Company Korrelasjon - Valuta/Råvare

-0.24
( neutral )

-0.34
( neutral )

0.00
( neutral )

0.12
( neutral )

0.34
( neutral )

0.23
( neutral )

Scilex Holding Company Økonomi

Annual	2023
Omsetning:	$46.74M
Bruttogevinst:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2023
Omsetning:	$46.74M
Bruttogevinst:	$26.92M (57.58 %)
EPS:	$-0.880

FY	2022
Omsetning:	$38.03M
Bruttogevinst:	$27.24M (71.61 %)
EPS:	$-0.170

Financial Reports:

No articles found.

Scilex Holding Company Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Scilex Holding Company

Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid therapies for patients with acute and chronic pain. The company\'s principal product includes ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain. It also offers SP-102 or SEMDEXA, a viscous gel formulation of corticosteroid for epidural injections that is in a Phase 3 clinical trial to treat lumbosacral radicular pain; SP-103 for the treatment of low back pain, which is in Phase 2 clinical trails; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia that is in Phase 1 clinical trials. The company is headquartered in Palo Alto, California. Scilex Holding Company is a subsidiary of Sorrento Therapeutics, Inc.